TreeWAS – Variant ID: rs527409

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	No effect posterior probability	Protective posterior probability
Chapter II Neoplasms	0.260	0.740
C15-C26 Malignant neoplasms of digestive organs	0.263	0.737
C18 Malignant neoplasm of colon	0.265	0.735
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.275	0.725
C18.9 Colon, unspecified	0.279	0.721
C64-C68 Malignant neoplasms of urinary tract	0.286	0.714
C51-C58 Malignant neoplasms of female genital organs	0.292	0.708
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.295	0.705
C80 Malignant neoplasm without specification of site	0.316	0.684
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.316	0.684
C54 Malignant neoplasm of corpus uteri	0.318	0.682
C26 Malignant neoplasm of other and ill-defined digestive organs	0.324	0.676
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.325	0.675
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.331	0.669
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.331	0.669
C54.1 Endometrium	0.338	0.662
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.339	0.661
C79 Secondary malignant neoplasm of other sites	0.340	0.660
C18.7 Sigmoid colon	0.342	0.658
C67 Malignant neoplasm of bladder	0.346	0.654
C18.6 Descending colon	0.358	0.642
C55 Malignant neoplasm of uterus, part unspecified	0.363	0.637
C17 Malignant neoplasm of small intestine	0.365	0.635
C19 Malignant neoplasm of rectosigmoid junction	0.369	0.631
C65 Malignant neoplasm of renal pelvis	0.370	0.630
C78.7 Secondary malignant neoplasm of liver	0.373	0.627
C92 Myeloid leukaemia	0.378	0.622
C71 Malignant neoplasm of brain	0.380	0.620
C26.0 Intestinal tract, part unspecified	0.384	0.616
C73 Malignant neoplasm of thyroid gland	0.389	0.611
C80.0 Malignant neoplasm, primary site unknown, so stated	0.391	0.609
C80.9 Malignant neoplasm, unspecified	0.392	0.608
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.393	0.607
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.397	0.603
C67.2 Lateral wall of bladder	0.402	0.598
C67.4 Posterior wall of bladder	0.405	0.595
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.418	0.582
C23 Malignant neoplasm of gallbladder	0.421	0.579
C53 Malignant neoplasm of cervix uteri	0.423	0.577
D37-D48 Neoplasms of uncertain or unknown behaviour	0.427	0.573
C91 Lymphoid leukaemia	0.429	0.571
C18.3 Hepatic flexure	0.436	0.563
C64 Malignant neoplasm of kidney, except renal pelvis	0.440	0.560
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.440	0.560
C18.8 Overlapping lesion of colon	0.441	0.559
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.448	0.552
C45 Mesothelioma	0.450	0.550
C82.1 Mixed small cleaved and large cell, follicular	0.453	0.547
C79.2 Secondary malignant neoplasm of skin	0.457	0.543
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.457	0.542
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.458	0.542
C18.2 Ascending colon	0.459	0.541
C92.1 Chronic myeloid leukaemia	0.459	0.541
C26.9 Ill-defined sites within the digestive system	0.463	0.537
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.464	0.536
C67.1 Dome of bladder	0.465	0.535
C18.5 Splenic flexure	0.466	0.534
C69 Malignant neoplasm of eye and adnexa	0.468	0.532
C79.6 Secondary malignant neoplasm of ovary	0.469	0.531
C88 Malignant immunoproliferative diseases	0.471	0.529
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.472	0.528
C95 Leukaemia of unspecified cell type	0.474	0.525
C66 Malignant neoplasm of ureter	0.476	0.524
C82.4 Follicular lymphoma grade IIIb	0.476	0.524
C86 Other specified types of T/NK-cell lymphoma	0.478	0.522
C74 Malignant neoplasm of adrenal gland	0.481	0.519
C16 Malignant neoplasm of stomach	0.483	0.517
C71.0 Cerebrum, except lobes and ventricles	0.483	0.517
C79.7 Secondary malignant neoplasm of adrenal gland	0.484	0.516
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.484	0.516
C84 Peripheral and cutaneous T-cell lymphomas	0.485	0.515
C18.0 Caecum	0.489	0.510
C71.8 Overlapping lesion of brain	0.490	0.510
C40-C41 Malignant neoplasms of bone and articular cartilage	0.491	0.509
C94 Other leukaemias of specified cell type	0.492	0.508
C83 Diffuse non-Hodgkin's lymphoma	0.492	0.508
C58 Malignant neoplasm of placenta	0.492	0.508
C93 Monocytic leukaemia	0.493	0.507
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.494	0.505
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.495	0.505
C70 Malignant neoplasm of meninges	0.496	0.503
C17.2 Ileum	0.497	0.503
C54.9 Corpus uteri, unspecified	0.500	0.500
C68 Malignant neoplasm of other and unspecified urinary organs	0.502	0.498
C82.0 Small cleaved cell, follicular	0.503	0.497
C92.7 Other myeloid leukaemia	0.503	0.497
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.504	0.496
C49 Malignant neoplasm of other connective and soft tissue	0.504	0.495
C57 Malignant neoplasm of other and unspecified female genital organs	0.506	0.494
C53.9 Cervix uteri, unspecified	0.506	0.494
C17.0 Duodenum	0.507	0.492
C82.2 Large cell, follicular	0.509	0.490
C54.8 Overlapping lesion of corpus uteri	0.511	0.489
C54.3 Fundus uteri	0.511	0.489
C54.2 Myometrium	0.511	0.489
C54.0 Isthmus uteri	0.511	0.489
C91.1 Chronic lymphocytic leukaemia	0.511	0.489
C17.9 Small intestine, unspecified	0.511	0.489
C26.8 Overlapping lesion of digestive system	0.515	0.485
C26.1 Spleen	0.515	0.485
C78.4 Secondary malignant neoplasm of small intestine	0.517	0.483
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.519	0.481
C17.1 Jejunum	0.520	0.480
C82.6 Cutaneous follicle centre lymphoma	0.520	0.480
C82.5 Diffuse follicle centre lymphoma	0.520	0.480
C67.3 Anterior wall of bladder	0.524	0.476
C71.1 Frontal lobe	0.525	0.475
C71.7 Brain stem	0.525	0.475
C46 Kaposi's sarcoma	0.526	0.474
C71.4 Occipital lobe	0.526	0.474
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.526	0.474
C48.2 Peritoneum, unspecified	0.526	0.474
C67.7 Urachus	0.531	0.469
C82.3 Follicular lymphoma grade IIIa	0.531	0.469
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.531	0.469
C92.4 Acute promyelocytic leukaemia	0.532	0.468
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.532	0.467
C67.6 Ureteric orifice	0.534	0.465
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.536	0.464
C71.6 Cerebellum	0.537	0.462
C51 Malignant neoplasm of vulva	0.538	0.462
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.539	0.461
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.539	0.461
C75 Malignant neoplasm of other endocrine glands and related structures	0.542	0.458
C45.9 Mesothelioma, unspecified	0.543	0.457
C18.4 Transverse colon	0.544	0.456
C76 Malignant neoplasm of other and ill-defined sites	0.544	0.456
C17.8 Overlapping lesion of small intestine	0.545	0.455
C17.3 Meckel's diverticulum	0.545	0.455
C78.1 Secondary malignant neoplasm of mediastinum	0.548	0.452
C92.2 Subacute myeloid leukaemia	0.549	0.451
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.554	0.446
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.554	0.446
C92.3 Myeloid sarcoma	0.554	0.446
C71.5 Cerebral ventricle	0.555	0.445
C92.5 Acute myelomonocytic leukaemia	0.556	0.444
C78.0 Secondary malignant neoplasm of lung	0.559	0.441
C71.3 Parietal lobe	0.559	0.440
C06 Malignant neoplasm of other and unspecified parts of mouth	0.559	0.440
C52 Malignant neoplasm of vagina	0.560	0.440
C81 Hodgkin's disease	0.561	0.439
C02 Malignant neoplasm of other and unspecified parts of tongue	0.564	0.436
C48.0 Retroperitoneum	0.565	0.435
C71.2 Temporal lobe	0.565	0.434
C01 Malignant neoplasm of base of tongue	0.566	0.434
C92.9 Myeloid leukaemia, unspecified	0.567	0.433
C67.8 Overlapping lesion of bladder	0.567	0.433
D45 Polycythaemia vera	0.569	0.431
C24.1 Ampulla of Vater	0.571	0.429
C92.0 Acute myeloid leukaemia	0.571	0.429
C95.0 Acute leukaemia of unspecified cell type	0.574	0.426
C69.2 Retina	0.577	0.423
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.578	0.422
C79.9 Secondary malignant neoplasm, unspecified site	0.581	0.419
C78.2 Secondary malignant neoplasm of pleura	0.581	0.419
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.585	0.415
C84.4 Peripheral T-cell lymphoma	0.585	0.415
C45.7 Mesothelioma of other sites	0.585	0.415
C04 Malignant neoplasm of floor of mouth	0.586	0.414
C53.8 Overlapping lesion of cervix uteri	0.586	0.413
C53.1 Exocervix	0.586	0.413
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.586	0.413
D46 Myelodysplastic syndromes	0.587	0.413
C03 Malignant neoplasm of gum	0.588	0.412
C91.9 Lymphoid leukaemia, unspecified	0.588	0.412
C15 Malignant neoplasm of oesophagus	0.589	0.411
C91.8 Mature B-cell leukaemia Burkitt-type	0.591	0.409
C91.7 Other lymphoid leukaemia	0.591	0.409
C91.6 Prolymphocytic leukaemia of T-cell type	0.591	0.409
C91.3 Prolymphocytic leukaemia	0.591	0.409
C91.2 Subacute lymphocytic leukaemia	0.591	0.409
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.591	0.409
C49.3 Connective and soft tissue of thorax	0.593	0.407
C16.2 Body of stomach	0.595	0.405
C91.0 Acute lymphoblastic leukaemia	0.596	0.404
C91.4 Hairy-cell leukaemia	0.596	0.404
C11 Malignant neoplasm of nasopharynx	0.597	0.403
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.598	0.402
C67.5 Bladder neck	0.598	0.401
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.599	0.401
C00 Malignant neoplasm of lip	0.599	0.401
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.599	0.401
C69.6 Orbit	0.599	0.400
C45.1 Mesothelioma of peritoneum	0.601	0.399
C74.0 Cortex of adrenal gland	0.602	0.398
C67.0 Trigone of bladder	0.602	0.398
C69.4 Ciliary body	0.603	0.397
C22.9 Liver, unspecified	0.604	0.396
C16.8 Overlapping lesion of stomach	0.604	0.396
C71.9 Brain, unspecified	0.604	0.396
C24.0 Extrahepatic bile duct	0.604	0.396
C72.0 Spinal cord	0.604	0.395
C45.2 Mesothelioma of pericardium	0.605	0.394
C45.0 Mesothelioma of pleura	0.607	0.393
C05 Malignant neoplasm of palate	0.608	0.392
C86.5 Angioimmunoblastic T-cell lymphoma	0.609	0.391
C53.0 Endocervix	0.609	0.391
C48.1 Specified parts of peritoneum	0.609	0.391
C91.5 Adult T-cell leukaemia	0.609	0.390
C24.8 Overlapping lesion of biliary tract	0.611	0.389
C69.9 Eye, unspecified	0.612	0.388
C16.5 Lesser curvature of stomach, unspecified	0.613	0.387
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.613	0.386
D48.5 Skin	0.615	0.385
D37.9 Digestive organ, unspecified	0.616	0.384
C16.1 Fundus of stomach	0.616	0.384
C83.2 Mixed small and large cell (diffuse)	0.617	0.382
C74.1 Medulla of adrenal gland	0.618	0.382
C69.8 Overlapping lesion of eye and adnexa	0.619	0.381
C69.5 Lachrymal gland and duct	0.619	0.381
C69.1 Cornea	0.619	0.381
C83.5 Lymphoblastic (diffuse)	0.619	0.381
C79.8 Secondary malignant neoplasm of other specified sites	0.619	0.381
C74.9 Adrenal gland, unspecified	0.620	0.380
C88.9 Malignant immunoproliferative disease, unspecified	0.621	0.379
C88.7 Other malignant immunoproliferative diseases	0.621	0.379
C88.3 Immunoproliferative small intestinal disease	0.621	0.379
C88.2 Gamma heavy chain disease	0.621	0.379
C88.1 Alpha heavy chain disease	0.621	0.379
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.621	0.379
C18.1 Appendix	0.621	0.378
C25 Malignant neoplasm of pancreas	0.622	0.378
C83.7 Burkitt's tumour	0.623	0.377
C95.7 Other leukaemia of unspecified cell type	0.623	0.377
C95.2 Subacute leukaemia of unspecified cell type	0.623	0.377
C84.5 Other and unspecified T-cell lymphomas	0.625	0.375
C13 Malignant neoplasm of hypopharynx	0.625	0.375
C49.0 Connective and soft tissue of head, face and neck	0.625	0.375
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.625	0.374
C86.4 Blastic NK-cell lymphoma	0.625	0.374
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.625	0.374
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.625	0.374
C86.1 Hepatosplenic T-cell lymphoma	0.625	0.374
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.625	0.374
C70.0 Cerebral meninges	0.626	0.374
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.626	0.374
C21 Malignant neoplasm of anus and anal canal	0.627	0.373
C16.6 Greater curvature of stomach, unspecified	0.628	0.372
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.628	0.372
C88.0 Waldenstrom's macroglobulinaemia	0.628	0.371
C72.9 Central nervous system, unspecified	0.630	0.370
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.630	0.370
C72.5 Other and unspecified cranial nerves	0.630	0.370
C72.4 Acoustic nerve	0.630	0.370
C72.3 Optic nerve	0.630	0.370
C72.2 Olfactory nerve	0.630	0.370
C72.1 Cauda equina	0.630	0.370
C69.3 Choroid	0.630	0.370
C84.9 Mature T/NK-cell lymphoma, unspecified	0.630	0.369
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.630	0.369
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.630	0.369
C84.3 Lymphoepithelioid lymphoma	0.630	0.369
C84.2 T-zone lymphoma	0.630	0.369
C84.1 Sezary's diease	0.630	0.369
C16.3 Pyloric antrum	0.632	0.368
C08 Malignant neoplasm of other and unspecified major salivary glands	0.632	0.368
C49.1 Connective and soft tissue of upper limb, including shoulder	0.633	0.367
C93.1 Chronic monocytic leukaemia	0.634	0.365
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.635	0.365
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.635	0.365
C94.7 Other specified leukaemias	0.635	0.364
C94.5 Acute myelofibrosis	0.635	0.364
C94.3 Mast cell leukaemia	0.635	0.364
C94.2 Acute megakaryoblastic leukaemia	0.635	0.364
C94.1 Chronic erythraemia	0.635	0.364
C94.0 Acute erythraemia and erythroleukaemia	0.635	0.364
C83.6 Undifferentiated (diffuse)	0.636	0.364
C83.4 Immunoblastic (diffuse)	0.636	0.364
C93.9 Monocytic leukaemia, unspecified	0.636	0.364
C93.7 Other monocytic leukaemia	0.636	0.364
C93.3 Juvenile myelomonocytic leukaemia	0.636	0.364
C93.2 Subacute monocytic leukaemia	0.636	0.364
C93.0 Acute monocytic leukaemia	0.636	0.364
D48.7 Other specified sites	0.636	0.364
D38.1 Trachea, bronchus and lung	0.637	0.363
D37.1 Stomach	0.637	0.363
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.638	0.362
C96.8 Histiocytic sarcoma	0.638	0.362
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.638	0.362
C96.6 Unifocal Langerhans-cell histiocytosis	0.638	0.362
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.638	0.362
C96.4 Sarcoma of dendritic cells (accessory cells)	0.638	0.362
C96.3 True histiocytic lymphoma	0.638	0.362
C96.2 Malignant mast cell tumour	0.638	0.362
C96.1 Malignant histiocytosis	0.638	0.362
C96.0 Letterer-Siwe disease	0.638	0.362
D37.2 Small intestine	0.638	0.362
C70.9 Meninges, unspecified	0.639	0.361
C70.1 Spinal meninges	0.639	0.361
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.640	0.359
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.641	0.359
C84.8 Cutaneous T-cell lymphoma, unspecified	0.641	0.358
C16.4 Pylorus	0.642	0.358
C10 Malignant neoplasm of oropharynx	0.642	0.358
D48.3 Retroperitoneum	0.642	0.358
C68.8 Overlapping lesion of urinary organs	0.643	0.357
C68.1 Paraurethral glands	0.643	0.357
C95.9 Leukaemia, unspecified	0.643	0.357
C95.1 Chronic leukaemia of unspecified cell type	0.644	0.356
C49.8 Overlapping lesion of connective and soft tissue	0.645	0.355
C57.9 Female genital organ, unspecified	0.645	0.355
C57.7 Other specified female genital organs	0.646	0.354
C57.4 Uterine adnexa, unspecified	0.646	0.354
C57.3 Parametrium	0.646	0.354
C57.2 Round ligament	0.646	0.354
C57.1 Broad ligament	0.646	0.354
D37.4 Colon	0.646	0.354
C90 Multiple myeloma and malignant plasma cell neoplasms	0.646	0.354
C57.8 Overlapping lesion of female genital organs	0.647	0.352
C94.4 Acute panmyelosis	0.648	0.352
C49.9 Connective and soft tissue, unspecified	0.648	0.351
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.649	0.351
C68.9 Urinary organ, unspecified	0.649	0.351
C68.0 Urethra	0.650	0.350
C49.5 Connective and soft tissue of pelvis	0.650	0.350
C06.2 Retromolar area	0.651	0.349
C83.3 Large cell (diffuse)	0.651	0.348
C51.1 Labium minus	0.653	0.346
C49.6 Connective and soft tissue of trunk, unspecified	0.654	0.346
D37.6 Liver, gallbladder and bile ducts	0.654	0.346
C22.7 Other specified carcinomas of liver	0.655	0.345
C22.4 Other sarcomas of liver	0.655	0.345
C22.3 Angiosarcoma of liver	0.655	0.345
C22.2 Hepatoblastoma	0.655	0.345
C67.9 Bladder, unspecified	0.656	0.344
C69.0 Conjunctiva	0.656	0.344
D38.3 Mediastinum	0.656	0.344
C83.0 Small cell (diffuse)	0.656	0.344
C24.9 Biliary tract, unspecified	0.657	0.343
D46.9 Myelodysplastic syndrome, unspecified	0.657	0.343
D48.2 Peripheral nerves and autonomic nervous system	0.659	0.341
C57.0 Fallopian tube	0.659	0.341
D43.2 Brain, unspecified	0.660	0.340
C46.9 Kaposi's sarcoma, unspecified	0.660	0.340
C46.8 Kaposi's sarcoma of multiple organs	0.660	0.340
C46.7 Kaposi's sarcoma of other sites	0.660	0.340
C46.3 Kaposi's sarcoma of lymph nodes	0.660	0.340
C46.2 Kaposi's sarcoma of palate	0.660	0.340
C46.1 Kaposi's sarcoma of soft tissue	0.660	0.340
C46.0 Kaposi's sarcoma of skin	0.660	0.340
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.660	0.340
C49.4 Connective and soft tissue of abdomen	0.661	0.339
C06.9 Mouth, unspecified	0.662	0.338
C02.4 Lingual tonsil	0.662	0.337
C60-C63 Malignant neoplasms of male genital organs	0.663	0.337
C76.2 Abdomen	0.664	0.336
D44.4 Craniopharyngeal duct	0.664	0.335
D38.0 Larynx	0.665	0.334
D38.2 Pleura	0.666	0.334
C02.9 Tongue, unspecified	0.667	0.333
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.667	0.332
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.667	0.332
C47.6 Peripheral nerves of trunk, unspecified	0.667	0.332
C47.5 Peripheral nerves of pelvis	0.667	0.332
C47.4 Peripheral nerves of abdomen	0.667	0.332
C47.3 Peripheral nerves of thorax	0.667	0.332
C47.2 Peripheral nerves of lower limb, including hip	0.667	0.332
C47.0 Peripheral nerves of head, face and neck	0.667	0.332
D38.5 Other respiratory organs	0.667	0.332
C51.8 Overlapping lesion of vulva	0.668	0.331
C51.2 Clitoris	0.668	0.331
D37.7 Other digestive organs	0.668	0.332
C07 Malignant neoplasm of parotid gland	0.668	0.331
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.669	0.331
D38.6 Respiratory organ, unspecified	0.670	0.330
D38.4 Thymus	0.670	0.330
C75.5 Aortic body and other paraganglia	0.670	0.330
C75.8 Pluriglandular involvement, unspecified	0.671	0.328
C75.4 Carotid body	0.671	0.328
C75.3 Pineal gland	0.671	0.328
C75.2 Craniopharyngeal duct	0.671	0.328
C02.1 Border of tongue	0.672	0.327
C09 Malignant neoplasm of tonsil	0.672	0.327
C76.8 Overlapping lesion of other and ill-defined sites	0.673	0.327
C76.7 Other ill-defined sites	0.673	0.327
C76.5 Lower limb	0.673	0.327
C76.4 Upper limb	0.673	0.327
C12 Malignant neoplasm of pyriform sinus	0.673	0.327
C75.9 Endocrine gland, unspecified	0.673	0.327
C75.0 Parathyroid gland	0.674	0.326
C84.0 Mycosis fungoides	0.674	0.325
C15.3 Upper third of oesophagus	0.675	0.325
D48.4 Peritoneum	0.676	0.324
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.676	0.324
C51.0 Labium majus	0.677	0.323
C47.1 Peripheral nerves of upper limb, including shoulder	0.678	0.322
C81.7 Other Hodgkin's disease	0.678	0.321
C97 Malignant neoplasms of independent (primary) multiple sites	0.679	0.321
C16.9 Stomach, unspecified	0.679	0.321
D48.6 Breast	0.679	0.321
C83.1 Small cleaved cell (diffuse)	0.680	0.320
C06.0 Cheek mucosa	0.680	0.320
D46.5 Refractory anaemia with multi-lineage dysplasia	0.682	0.318
C50-C50 Malignant neoplasm of breast	0.682	0.318
C04.9 Floor of mouth, unspecified	0.683	0.317
C02.8 Overlapping lesion of tongue	0.684	0.316
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.684	0.316
C06.1 Vestibule of mouth	0.684	0.316
C03.1 Lower gum	0.684	0.316
D37.0 Lip, oral cavity and pharynx	0.684	0.315
C02.2 Ventral surface of tongue	0.685	0.315
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.685	0.315
C81.3 Lymphocytic depletion	0.685	0.315
D37.5 Rectum	0.685	0.315
C02.0 Dorsal surface of tongue	0.687	0.313
C76.3 Pelvis	0.687	0.312
C76.1 Thorax	0.689	0.311
D43.1 Brain, infratentorial	0.689	0.310
D44.1 Adrenal gland	0.689	0.310
D44.3 Pituitary gland	0.690	0.310
C75.1 Pituitary gland	0.690	0.310
C81.0 Lymphocytic predominance	0.693	0.307
C49.2 Connective and soft tissue of lower limb, including hip	0.694	0.306
D37.3 Appendix	0.694	0.306
C15.1 Thoracic part of oesophagus	0.694	0.306
C22.1 Intrahepatic bile duct carcinoma	0.694	0.305
C16.0 Cardia	0.695	0.304
C04.0 Anterior floor of mouth	0.696	0.303
D43.9 Central nervous system, unspecified	0.697	0.303
D43.7 Other parts of central nervous system	0.697	0.303
D43.3 Cranial nerves	0.697	0.303
C11.1 Posterior wall of nasopharynx	0.698	0.302
C02.3 Anterior two-thirds of tongue, part unspecified	0.698	0.302
C81.2 Mixed cellularity	0.699	0.300
C15.4 Middle third of oesophagus	0.701	0.299
C03.9 Gum, unspecified	0.702	0.297
C03.0 Upper gum	0.703	0.297
C04.8 Overlapping lesion of floor of mouth	0.703	0.297
C04.1 Lateral floor of mouth	0.703	0.297
C00.0 External upper lip	0.703	0.297
C05.0 Hard palate	0.703	0.297
D44.5 Pineal gland	0.703	0.296
D44.2 Parathyroid gland	0.703	0.296
D40.7 Other male genital organs	0.703	0.296
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.704	0.296
D46.3 Refractory anaemia with excess of blasts with transformation	0.704	0.296
C81.1 Nodular sclerosis	0.704	0.296
C00.1 External lower lip	0.705	0.295
C15.8 Overlapping lesion of oesophagus	0.705	0.295
C15.2 Abdominal part of oesophagus	0.705	0.295
D48.1 Connective and other soft tissue	0.706	0.294
C76.0 Head, face and neck	0.709	0.291
D44.0 Thyroid gland	0.709	0.291
C81.9 Hodgkin's disease, unspecified	0.709	0.291
D48.0 Bone and articular cartilage	0.709	0.290
C11.9 Nasopharynx, unspecified	0.710	0.289
C56 Malignant neoplasm of ovary	0.710	0.289
D40.0 Prostate	0.711	0.289
C05.9 Palate, unspecified	0.711	0.289
C11.8 Overlapping lesion of nasopharynx	0.711	0.289
C11.3 Anterior wall of nasopharynx	0.711	0.289
C11.2 Lateral wall of nasopharynx	0.711	0.289
C11.0 Superior wall of nasopharynx	0.711	0.289
D43.4 Spinal cord	0.711	0.289
C25.1 Body of pancreas	0.712	0.288
C00.8 Overlapping lesion of lip	0.712	0.288
C00.6 Commissure of lip	0.712	0.288
C00.5 Lip, unspecified, inner aspect	0.712	0.288
C00.4 Lower lip, inner aspect	0.712	0.288
C00.3 Upper lip, inner aspect	0.712	0.288
C00.2 External lip, unspecified	0.712	0.288
D40.9 Male genital organ, unspecified	0.712	0.288
C15.0 Cervical part of oesophagus	0.712	0.287
D42.1 Spinal meninges	0.712	0.287
D42.0 Cerebral meninges	0.712	0.287
C25.4 Endocrine pancreas	0.713	0.287
D46.0 Refractory anaemia without sideroblasts, so stated	0.713	0.287
C20 Malignant neoplasm of rectum	0.713	0.287
C85.7 Other specified types of non-Hodgkin's lymphoma	0.715	0.285
D46.4 Refractory anaemia, unspecified	0.716	0.284
D44.6 Carotid body	0.717	0.283
C00.9 Lip, unspecified	0.717	0.283
D44.9 Endocrine gland, unspecified	0.718	0.282
C85.0 Lymphosarcoma	0.718	0.282
D46.7 Other myelodysplastic syndromes	0.718	0.281
C05.8 Overlapping lesion of palate	0.719	0.281
C05.2 Uvula	0.719	0.281
D44.8 Pluriglandular involvement	0.721	0.279
D42.9 Meninges, unspecified	0.723	0.277
D46.1 Refractory anaemia with sideroblasts	0.723	0.277
C51.9 Vulva, unspecified	0.725	0.275
C13.9 Hypopharynx, unspecified	0.729	0.271
D43.0 Brain, supratentorial	0.729	0.271
C41.1 Mandible	0.729	0.270
C13.8 Overlapping lesion of hypopharynx	0.731	0.269
C13.2 Posterior wall of hypopharynx	0.731	0.269
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.731	0.269
C21.2 Cloacogenic zone	0.732	0.267
D44.7 Aortic body and other paraganglia	0.733	0.267
D39.9 Female genital organ, unspecified	0.733	0.266
D39.2 Placenta	0.733	0.266
C41.2 Vertebral column	0.733	0.266
D40.1 Testis	0.734	0.265
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.735	0.265
C08.8 Overlapping lesion of major salivary glands	0.736	0.264
C08.1 Sublingual gland	0.736	0.264
D46.2 Refractory anaemia with excess of blasts	0.736	0.264
C25.3 Pancreatic duct	0.737	0.263
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)	0.738	0.262
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)	0.738	0.262

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations